1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, SJ; Jung, DB; Jung, JH; Kim, JH; Kim, SH; Kwon, TR; Lee, HJ; Lu, J; Sohn, EJ | 1 |
1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Reactive oxygen species-mediated activation of JNK and down-regulation of DAXX are critically involved in penta-O-galloyl-beta-d-glucose-induced apoptosis in chronic myeloid leukemia K562 cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Co-Repressor Proteins; Down-Regulation; Enzyme Activation; HL-60 Cells; Humans; Hydrolyzable Tannins; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Kinase 4; Molecular Chaperones; Myeloid Cell Leukemia Sequence 1 Protein; Nuclear Proteins; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2012 |